Post-approval studies (Phase 4)Study completedNCT03346070
What this trial is testing
Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)
Who this might be right for
Neuromuscular Blockade
Merck Sharp & Dohme LLC 207